These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10519976)

  • 21. Pituitary adenylate cyclase-activating polypeptide- and VIP-induced activation of adenylate cyclase in the porcine non-pigmented ciliary epithelium: effects of antagonists.
    Samuelsson-Almén M; Nilsson SF
    J Ocul Pharmacol Ther; 1999 Oct; 15(5):389-400. PubMed ID: 10530700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of pituitary adenylate cyclase-activating polypeptide on cerebral arteries and vertebral artery blood flow in anesthetized dogs.
    Seki Y; Suzuki Y; Baskaya MK; Kano T; Saito K; Takayasu M; Shibuya M; Sugita K
    Eur J Pharmacol; 1995 Mar; 275(3):259-66. PubMed ID: 7768293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular effects of pituitary adenylate cyclase activating peptide: a comparison with vasoactive intestinal peptide.
    Absood A; Chen D; Wang ZY; Håkanson R
    Regul Pept; 1992 Aug; 40(3):323-9. PubMed ID: 1332142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary adenylyl cyclase-activating polypeptides and vasoactive intestinal peptide inhibit bone resorption by isolated rabbit osteoclasts.
    Winding B; Wiltink A; Foged NT
    Exp Physiol; 1997 Sep; 82(5):871-86. PubMed ID: 9331555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasorelaxant effect of PACAP-27 on canine cerebral arteries and rat intracerebral arterioles.
    Anzai M; Suzuki Y; Takayasu M; Kajita Y; Mori Y; Seki Y; Saito K; Shibuya M
    Eur J Pharmacol; 1995 Oct; 285(2):173-9. PubMed ID: 8566136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of VIP and PACAP on basal release of serotonin from isolated vascularly and luminally perfused rat duodenum.
    Fujimiya M; Yamamoto H; Kuwahara A
    Am J Physiol; 1998 Oct; 275(4):G731-9. PubMed ID: 9756504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cyclic AMP effects and neuroprotective activities of PACAP and VIP in cultured astrocytes and neurons exposed to oxygen-glucose deprivation.
    Jóźwiak-Bębenista M; Kowalczyk E; Nowak JZ
    Pharmacol Rep; 2015 Apr; 67(2):332-8. PubMed ID: 25712659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The vasorelaxant effect of pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in isolated rat basilar arteries is partially mediated by activation of nitrergic neurons.
    Seebeck J; Löwe M; Kruse ML; Schmidt WE; Mehdorn HM; Ziegler A; Hempelmann RG
    Regul Pept; 2002 Jul; 107(1-3):115-23. PubMed ID: 12137973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary adenylate cyclase activating polypeptide can regulate testicular germ cell protein synthesis in vitro.
    West AP; McKinnell C; Sharpe RM; Saunders PT
    J Endocrinol; 1995 Feb; 144(2):215-23. PubMed ID: 7706975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoactive intestinal peptide (VIP) like peptides in the cerebral circulation of the cat.
    Jansen-Olesen I; Goadsby PJ; Uddman R; Edvinsson L
    J Auton Nerv Syst; 1994 Sep; 49 Suppl():S97-103. PubMed ID: 7836694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pituitary adenylate cyclase activating polypeptide-27 (PACAP-27) inhibits pentagastrin-stimulated gastric acid secretion in conscious rats.
    Mungan Z; Ozmen V; Ertan A; Arimura A
    Regul Pept; 1992 Apr; 38(3):199-206. PubMed ID: 1589595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of VIP, PACAP and related peptides in normal and leukemic human monocytes and macrophages.
    Chedeville A; Mirossay L; Chastre E; Hurbain-Kosmath I; Lopez M; Gespach C
    FEBS Lett; 1993 Mar; 319(1-2):171-6. PubMed ID: 8384124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, and noradrenaline induce the transcription factors CCAAT/enhancer binding protein (C/EBP)-beta and C/EBP delta in mouse cortical astrocytes: involvement in cAMP-regulated glycogen metabolism.
    Cardinaux JR; Magistretti PJ
    J Neurosci; 1996 Feb; 16(3):919-29. PubMed ID: 8558260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The differential effect of VIP and PACAP on guinea pig gallbladder in vitro.
    Greaves RR; O'Donnell LJ; Battistini B; Forget MA; Farthing MJ
    Eur J Gastroenterol Hepatol; 2000 Nov; 12(11):1181-4. PubMed ID: 11111773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PACAP-induced plasma extravasation in rat skin.
    Cardell LO; Stjärne P; Wagstaff SJ; Agustí C; Nadel JA
    Regul Pept; 1997 Aug; 71(2):67-71. PubMed ID: 9416988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary adenylate cyclase-activating polypeptides (PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP.
    Delgado M; De la Fuente M; Martínez C; Gomariz RP
    J Neuroimmunol; 1995 Nov; 62(2):137-46. PubMed ID: 7499501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pituitary adenylate cyclase-activating polypeptide relaxes rat gastrointestinal smooth muscle.
    Mungan Z; Arimura A; Ertan A; Rossowski WJ; Coy DH
    Scand J Gastroenterol; 1992 May; 27(5):375-80. PubMed ID: 1529272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of PEDF and VEGF on PACAP-/VIP-induced cAMP formation in rat brain derived astrocyte cultures.
    Klaska I; Bednarek K; Nowak JZ
    Pharmacol Rep; 2008; 60(6):1019-24. PubMed ID: 19211999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of neuropeptides on vessel tone and cAMP production.
    Yao W; Sheikh SP; Ottesen B; Jørgensen JC
    Ann N Y Acad Sci; 1996 Dec; 805():784-8. PubMed ID: 8993477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of GHRH and peptides from the vasoactive intestinal peptide family on cAMP production of human cancer cell lines in vitro.
    Csernus V; Schally AV; Groot K
    J Endocrinol; 1999 Nov; 163(2):269-80. PubMed ID: 10556777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.